We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




In Vitro Three-Dimensional Culture System Enhances Prostate Cancer Cell Growth

By LabMedica International staff writers
Posted on 07 Jul 2016
A team of cancer researchers developed a three-dimensional in vitro culture system for growing prostate cancer cells in an environment that closely mimics the in vivo tumor microenvironment.

The physical and mechanical properties of the tumor microenvironment are crucial for the growth, differentiation, and migration of cancer cells. More...
However, such a microenvironment is not reproduced in vitro due to the geometric constraints of the classic two-dimensional cell culture systems used in many cancer studies. Prostate cancer research, in particular, suffers from the lack of suitable in vitro models.

To correct this deficiency, investigators at the Karlsruhe Institute of Technology (Eggenstein-Leopoldshafen, Germany) generated a three-dimensional in vitro growth system based on a superporous scaffold prepared by cryogelation of poly(ethylene glycol) diacrylate. The resulting structure was a defined elastic matrix for prostate tumor growth with mechanical properties that were very similar to those of natural cell tissue.

The investigators reported in the May 30, 2016, online edition of the journal Small that lymph node carcinoma of the prostate (LNCaP) cells showed a linear growth over 21 days as multicellular tumor spheroids in such a scaffold with points of attachments to the walls of the scaffold. These LNCaP cells responded to the growth promoting effects of androgens and demonstrated a characteristic cytoplasmic-nuclear translocation of the androgen receptor and androgen-dependent gene expression.

Compared to two-dimensional cell culture, the expression or androgen response of prostate cancer specific genes was greatly enhanced in the LNCaP cells grown in the three-dimensional system.

"The paper covers the implementation of the model and shows that it is a long-term stable tissue-like three-dimensional cell culture system, with the help of which hormone-independent prostate-specific gene expression could not only be achieved, but even be reinforced compared to conventional two-dimensional models," said contributing author Dr. Friederike J. Gruhl, a researcher in the Institute of Microstructure Technology at the Karlsruhe Institute of Technology. "This was shown by the cultivation of androgen-sensitive prostate cancer cells (LNCaP). In future, it may be possible to cultivate both healthy cells of the prostate tissue and cancer cells in the three-dimensional cryogel model. This opens up new opportunities for preclinical research and for using it in the clinical development of anti-prostate cancer drugs."

Related Links:
Karlsruhe Institute of Technology


New
Gold Member
Automatic Hematology Analyzer
CF9600
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Total Laboratory Automation Solution
SATLARS Mini T8
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.